At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
---|---|---|---|---|---|
Diabetes estimates (20-79 y) | |||||
People with diabetes, in 1,000s | 3,310.4 | 12,440.0 | 15,733.6 | 19,224.1 | 23,223.6 |
Age-adjusted comparative prevalence of diabetes, % | - | 10.1 | 8.8 | 10.2 | 10.9 |
People with undiagnosed diabetes, in 1,000s | - | - | 5,025.3 | - | - |
Proportion of people with undiagnosed diabetes, % | - | - | 31.9 | - | - |
Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
People with IGT, in 1,000s | - | 5,354.5 | 17,774.9 | 20,249.9 | 22,468.8 |
Age-adjusted comparative prevalence of IGT, % | - | 4.3 | 10.8 | 11.4 | 11.7 |
Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
People with IFG, in 1,000s | - | - | 21,425.6 | 24,361.5 | 26,930.1 |
Age-adjusted comparative prevalence of IFG, % | - | - | 9.9 | 10.3 | 10.5 |
Mortality attributable to diabetes (20-79 y) | |||||
Deaths attributable to diabetes | - | 121,082.0 | 214,175.0 | - | - |
Proportion of diabetes-related deaths in people under 60 y, % | - | - | 2.8 | - | - |
Type 1 diabetes estimates in children and adolescents | |||||
New cases of type 1 diabetes (0-14 y), in 1,000s | 4.4 | 0.1 | 7.1 | - | - |
New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 8.9 | - | - |
Type 1 diabetes (0-14 y), in 1,000s | 19.9 | - | 49.9 | - | - |
Type 1 diabetes (0-19 y), in 1,000s | - | - | 92.4 | - | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
Live births affected by HIP | - | - | 298,237.1 | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | 10.6 | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | 18,924.4 | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | 40,325.5 | - | - |
Diabetes-related health expenditure | |||||
Total diabetes-related health expenditure, USD million | - | - | 42,928.5 | 48,308.7 | 51,441.2 |
Total diabetes-related health expenditure, ID million | - | - | 77,459.7 | 87,167.6 | 92,819.9 |
Diabetes-related health expenditure per person, USD | - | 1,038.0 | 2,728.5 | 3,070.4 | 3,269.5 |
Diabetes-related health expenditure per person, ID | - | - | 4,923.2 | 5,540.2 | 5,899.5 |
Demographics | |||||
Total adult population (20-79 y), in 1,000s | 102,431.0 | 127,994.8 | 149,916.8 | 161,892.7 | 169,190.2 |
Population of children (0-14 y), in 1,000s | 58,042.0 | - | 43,762.9 | - | - |
Population of children and adolescents (0-19 y), in 1,000s | - | - | 59,701.5 | - | - |
Complications of diabetes | |||||
Microvascular |
| ||||
Macrovascular |
|